- Report
- May 2024
- 130 Pages
Global
From €5751EUR$6,499USD£4,973GBP
- Report
- May 2024
- 138 Pages
Global
From €5751EUR$6,499USD£4,973GBP
- Report
- May 2024
- 134 Pages
Global
From €5751EUR$6,499USD£4,973GBP
- Report
- May 2024
- 130 Pages
Global
From €5751EUR$6,499USD£4,973GBP
- Report
- May 2024
- 128 Pages
Global
From €5751EUR$6,499USD£4,973GBP
- Report
- January 2023
- 50 Pages
China
From €2655EUR$3,000USD£2,295GBP
- Report
- July 2022
- 40 Pages
China
From €2831EUR$3,200USD£2,448GBP
- Report
- September 2021
- 40 Pages
China
From €2301EUR$2,600USD£1,989GBP
- Report
- September 2021
- 40 Pages
China
From €2301EUR$2,600USD£1,989GBP
- Report
- July 2021
- 50 Pages
China
From €2301EUR$2,600USD£1,989GBP
- Report
- May 2021
- 50 Pages
China
From €2301EUR$2,600USD£1,989GBP
- Report
- April 2021
China
From €2301EUR$2,600USD£1,989GBP
- Report
- October 2018
- 30 Pages
China
From €1947EUR$2,200USD£1,683GBP
- Report
- April 2022
- 116 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- July 2024
- 100 Pages
Global
From €3318EUR$3,750USD£2,869GBP
- Report
- June 2024
- 200 Pages
Global
From €7035EUR$7,950USD£6,083GBP
- Report
- June 2024
- 200 Pages
Global
From €7035EUR$7,950USD£6,083GBP
- Report
- June 2024
- 200 Pages
Global
From €7035EUR$7,950USD£6,083GBP
- Report
- June 2024
- 200 Pages
Global
From €7035EUR$7,950USD£6,083GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4380EUR$4,950USD£3,787GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more